Peer Review History

Original SubmissionSeptember 15, 2020
Decision Letter - Fabio Santanelli, di Pompeo d'Illasi, Editor

PONE-D-20-28837

Efficacy, safety and complications of autologous fat grafting for rejuvenation of eyelids and periorbital area:  A systematic review and meta-analysis

PLOS ONE

Dear Dr. Zhang,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 21 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Fabio Santanelli, di Pompeo d'Illasi, MD, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.  

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

  • The name of the colleague or the details of the professional service that edited your manuscript
  • A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)
  • A clean copy of the edited manuscript (uploaded as the new *manuscript* file)

3. At this time, we ask that you please provide the full search strategy and search terms for at least one database used as Supplementary Information.

4. Please provide the date ranges for the database searches you performed.

5. Please attach a Supplemental file of the results of the individual components of the quality assessment, not just the overall score, for each study included. Please also explain the reasons, and number of studies excluded for each reason, in the flow diagram. Thank you.

6. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"This study was funded by National Natural Science Foundations of China (81773488, 81772096 and 81803289)"

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"No"

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

7. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

8. We note that Figure 2 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

8.1.    You may seek permission from the original copyright holder of Figure 2 to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

8.2.    If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I have read with great interest the manuscript entitled "Efficacy, safety and complications of autologous fat grafting for rejuvenation of eyelids and periorbital area: A systematic review and meta-analysis". These are my comments to the authors.

1) In the abstract although the authors introduce the abbreviation AFG for autologous fat grafting, they go back to using autologous fat grafting and not AFG in their conclusion. Please check the manuscript and correct this minor error

2) In the abstract in the conclusion section they report that "AFG might be....and reconstruction) the title of the manuscript refers to evaluation of AFG in rejuvenation, i think the connection of AFG to the reconstruction of the periorbital region is not appropriate. I advice to only use the periorbital rejuvenation and contour defects.

3)Line 56 the word isolation is misspelled as insolation

4)In the exclusion criteria line 85-86 the authors refer to patients with a history of other eyelid surgery but then give an example of periorbital rejuvenation and "reconstruction" with hyaluronic acid. Hyaluronic acid is used for rejuvenation and contour correction not for reconstruction and it is not a surgical procedure. The authors should specify and make this exclusion criteria clear to the read as to what they mean.

5) Line 473 a citation is mentioned as INVALID CITATION. The authors should check the references for errors

6) The article is generally well written but minor reviewing of language is needed.

Reviewer #2: thank you very much to give me the opportunity to review this article. the authors made a systematic review using international guidelines and it is correct. i think that the meta anaysis is poor and did not support the conclusions. it is important to do a meta analysis with high methods to support the high quality of the journal and the topic treated.

i suggest to made a flow chart diagram of the review.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Dear Editor,

We would like to express sincere gratitude for your letter and advice. We have revised the manuscript in accordance with the point raised by the academic editor and reviewers. Point-to-point answers have been provided below.

Manuscript title: Efficacy, safety and complications of autologous fat grafting for rejuvenation of eyelids and periorbital area: A systematic review and meta-analysis

Academic editor

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Answer: Thank you for your comment. We have checked manuscript to meet the style requirements.

2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.

Answer: Thank you very much for your advice. We have sought help from the professional scientific editing service. Here is our Certi¬ficate of English Language Editing.

3. At this time, we ask that you please provide the full search strategy and search terms for at least one database used as Supplementary Information.

Answer: Thank you very much for your advice. We have revised in the Supporting Information files. Specifically speaking, we provide the full search strategy and search terms for PubMed and Cochrane library in details. The following highlight parts have been added as the supplementary information.

PubMed

#1 ((((((((((fat grafting) OR (lipograft)) OR (lipoinjection)) OR (lipotransfer)) OR (fat transfer)) OR (fat transplant)) OR (lipostructure)) OR (lipofilling)) OR (fat injection)) OR (lipomodeling)) OR (fat transplantation) Sort by: Most Recent 23199

#2 (eyelid) OR (periocular) Sort by: Most Recent 49264

#3 #1 AND #2 324

Cochrane

(fat grafting OR lipograft OR lipoinjection OR lipotransfer OR fat transfer OR fat transplant OR lipostructure OR lipofilling OR fat injection OR lipomodeling OR fat transplantation) in All Text AND (eyelid OR periocular) in All Text - (Word variations have been searched) 10

The date ranges for the database searches (before November 1, 2019)

4. Please provide the date ranges for the database searches you performed.

Answer: Thank you very much for your advice. Likewise, we have revised in the Supporting Information files. We provide the data ranges for the database searches. The following highlight parts have been added as the supplementary information.

PubMed

#1 ((((((((((fat grafting) OR (lipograft)) OR (lipoinjection)) OR (lipotransfer)) OR (fat transfer)) OR (fat transplant)) OR (lipostructure)) OR (lipofilling)) OR (fat injection)) OR (lipomodeling)) OR (fat transplantation) Sort by: Most Recent 23199

#2 (eyelid) OR (periocular) Sort by: Most Recent 49264

#3 #1 AND #2 324

Cochrane

(fat grafting OR lipograft OR lipoinjection OR lipotransfer OR fat transfer OR fat transplant OR lipostructure OR lipofilling OR fat injection OR lipomodeling OR fat transplantation) in All Text AND (eyelid OR periocular) in All Text - (Word variations have been searched) 10

The date ranges for the database searches (before November 1, 2019)

5. Please attach a Supplemental file of the results of the individual components of the quality assessment, not just the overall score, for each study included. Please also explain the reasons, and number of studies excluded for each reason, in the flow diagram. Thank you.

Answer: Thank you very much for your advice and we agree with you. We have given the individual scores for each study included, which will provide studies a clear quality assessment. The revised edition can be found in the Supporting Information files. And the flow diagram has been done in the Figure files.

NR: not reported

6. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"This study was funded by National Natural Science Foundations of China (81773488, 81772096 and 81803289) We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Answer: Thank you very much for your advice. We apologize for the confusion regarding the funding statement. We have revised our Funding Statement in the online submission form.

7. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Answer: Thank you very much for your advice. We have provided the minimal data set in the Supporting Information files. We are very supportive of the Data Availability statement. So, we provide the raw data as clearly as possible with the belief that this behavior will promote academic development.

8. We note that Figure 2 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

Answer: Thank you very much for your advice. We apologize for the confusion made in the Figure 2. Without taking the copyright into full consideration, we use the map downloaded from the internet. We have made a new “geographic distribution” map by the software “Hiplot”. The new picture can be found in the Figure files.

Reviewer #1: I have read with great interest the manuscript entitled "Efficacy, safety and complications of autologous fat grafting for rejuvenation of eyelids and periorbital area: A systematic review and meta-analysis". These are my comments to the authors.

1) In the abstract although the authors introduce the abbreviation AFG for autologous fat grafting, they go back to using autologous fat grafting and not AFG in their conclusion. Please check the manuscript and correct this minor error

Answer: Thank you very much for your advice. We apologize for the mistake made in the manuscript. We have revised the error, undoubtedly, this is our mistake, thanks for reminding us.

2) In the abstract in the conclusion section they report that "AFG might be....and reconstruction) the title of the manuscript refers to evaluation of AFG in rejuvenation, i think the connection of AFG to the reconstruction of the periorbital region is not appropriate. I advice to only use the periorbital rejuvenation and contour defects.

Answer: Thank you very much for your advice and we totally agree with you. We apologize for the confusion made in the title. We have revised the title to “Efficacy, safety and complications of autologous fat grafting to the eyelids and periorbital area: A systematic review and meta-analysis”. Indications in the meta-analysis concern a lot of diseases such as aging eyelids, tear trough deformity and anophthalmic reconstruction. The former title cannot give an all-around description of the content.

3)Line 56 the word isolation is misspelled as insolation

Answer: Thank you very much for your advice. We apologize for the spelling mistake in the manuscript. We have revised the content. We shouldn’t have made such a simple grammatical mistake.

4)In the exclusion criteria line 85-86 the authors refer to patients with a history of other eyelid surgery but then give an example of periorbital rejuvenation and "reconstruction" with hyaluronic acid. Hyaluronic acid is used for rejuvenation and contour correction not for reconstruction and it is not a surgical procedure. The authors should specify and make this exclusion criteria clear to the read as to what they mean.

Answer: Thank you very much for your advice. And we apologize for the confusion made in the manuscript. In the paper titled “the Tear trough deformity: different types of anatomy and treatment options”, the author incorporated seventy-eight patients with tear trough deformity. Moreover, he rated them as three class. Ten cases in their series were classified as class I, eighteen cases as class II and fifty cases as class III. Patients of class I or class II were treated using hyaluronic acid gel (18 cases) or autologous fat injections (10 cases). The author explicitly differentiated between patients received hyaluronic acid and those who got the autologous fat injection. And we excluded ones treated by hyaluronic acid. So, finally, we contained ten patients who received autologous fat. As you said, hyaluronic acid is neither a surgical procedure nor for reconstruction. I apologize for the mistake made in the inclusion and exclusion criteria. We have changed the inappropriate expression in the manuscript.

5) Line 473 a citation is mentioned as INVALID CITATION. The authors should check the references for errors

Answer: Thank you very much for your advice. We apologize for the mistake. We have revised in the reference part.

6) The article is generally well written but minor reviewing of language is needed.

Answer: Thank you very much for your advice. Owing to the limited writing skill, we cannot write paper like native speakers. So, we seek help from a professional scientific editing service. We have provided the Certi¬ficate of English Language Editing in the Supporting Information files.

Reviewer #2: thank you very much to give me the opportunity to review this article. the authors made a systematic review using international guidelines and it is correct. I think that the meta analysis is poor and did not support the conclusions. it is important to do a meta analysis with high methods to support the high quality of the journal and the topic treated.

i suggest to made a flow chart diagram of the review.

Answer: Thank you very much for your advice and we have considered your comments carefully. Indeed, there were several limitations in this study. First, nearly all of the articles in this meta-analysis were case series, obviously, low quality. There was a lack of access to RCTs, on account of setting RCTs might be viewed as unnecessary or unethical. So, we conducted quality evaluation in accordance with the international scale, for example, the Ottawa-Newcastle Scale, to evaluate the included literatures more objectively. Besides, we used a blinded method to ensure quality and a third reviewer resolved any disagreements. Second, the follow-up period seemed to present a lot of variability. According to already published theory, it will take 3 to 6 months for graft to reach a steady state. Thus, the studies included are followed over 3 months. Third, there was still debate about objective standards which could assess the validity of included studies. Studies included use a lot of objective scales, such as, 5-point Likert scale, grading scale, Fitzpatrick scale and so on. And we have made a flow chart diagram of the review in the “figure” file.

We thank you for your time and consideration and hope that the modified manuscript is now suitable for publication.

Sincerely yours,

Fan Yang

Department of Plastic Surgery and Burns,

Fourth Military Medical University,

Xi’an 710032, Shaanxi, China

Email: crystalyangfan@163.com

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Endi Lanza Galvão, Editor

PONE-D-20-28837R1

Efficacy, safety and complications of autologous fat grafting to the eyelids and periorbital area: A systematic review and meta-analysis

PLOS ONE

Dear Dr. Zhang,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but one single point must be addressed before the formal acceptance. Please provide the date ranges for the database searches you performed in the main file of the manuscript (Methods section - Search strategy) and states if any language restriction was applied in the search process. Therefore, we invite you to submit a revised version of the manuscript that addresses the point raised during the review process.

Please submit your revised manuscript by Apr 09 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Endi Lanza Galvão

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: the authors made the revisions requested and the manuscript improved. i think that the manuscript could be considered for publication in this form.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Dear Editors and Reviewers:

Thank you for your letter and for the reviewers’ comments concerning our manuscript entitled “Efficacy, safety and complications of autologous fat grafting to the eyelids and periorbital area: A systematic review and meta-analysis” (ID: PONE-D-20-28837R1). Those comments are all valuable and very helpful for revising and improving our paper, as well as the important guiding significance to our research. We have studied comments carefully and have made corrections which we hope to be met with approval. And we have uploaded the protocol to the protocols.io according to your requirements. Revised portion are marked with track changes in the paper. The main corrections in the paper are as follows:

Editor: Please provide the date ranges for the database searches you performed in the main file of the manuscript (Methods section - Search strategy) and states if any language restriction was applied in the search process.

Response: We are very sorry for our negligence of data range and language restriction. The specific information has been added to the methods section of the article.

A systematic database search was carried out before November 11, 2020. There were no restrictions with respect to language.

Thank you and best regards.

Yours sincerely,

Weilu Zhang

Email: zhangweilu@126.com

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Endi Lanza Galvão, Editor

Efficacy, safety and complications of autologous fat grafting to the eyelids and periorbital area: A systematic review and meta-analysis

PONE-D-20-28837R2

Dear Dr. Zhang,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Endi Lanza Galvão

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - Endi Lanza Galvão, Editor

PONE-D-20-28837R2

Efficacy, safety and complications of autologous fat grafting to the eyelids and periorbital area: A systematic review and meta-analysis

Dear Dr. Zhang:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Endi Lanza Galvão

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .